Search
for
Sort by
Research 271–300 of 1000+
- Skin Deep and Deeper: Multiple Pathways in Basal Cell Carcinogenesis
- Stem Cells Therapies in Basic Science and Translational Medicine: Current Status and Treatment Monitoring Strategies
- Cutaneous adverse events to systemic antineoplastic therapies: a retrospective study in a public oncologic hospital
- mRNA Levels of Aromatase, 5α-Reductase Isozymes, and Prostate Cancer-Related Genes in Plucked Hair from Young Men with Androgenic Alopecia
- Cell-Free Therapies: The Use of Cell Extracts to Mitigate Irradiation-Injured Salivary Glands
- Radiotherapy-Induced Skin Fibrosis: Pathophysiology, Emerging Therapeutics, and the Role of Dermatology
- A Review on Nanoparticle Based Herbal Remedies for the Management of Alopecia
- EMT Factors and Metabolic Pathways in Cancer
- Abstract CN06-04: The hedgehog signaling pathway in cancer.
- Role of sgk1 in cancer: a bibliometric analysis from 2013 to 2023—review article
- High-confidence cancer patient stratification through multiomics investigation of DNA repair disorders
- Copper-quercetin complexes: methods of study, relevance to cell death pathways, therapeutic applications
- Updated Treatment for Acne: Targeted Therapy Based on Pathogenesis
- Real World Evidence in Alopecia Areata: Current Management, Emerging Therapies and Future Challenges – A Narrative Review
- Hétérogénéité tumorale du cancer de la prostate et infection par le SARS-CoV2 : une relation complexe impliquant les vésicules extracellulaires et le récepteur des androgènes
- World Dermatologic Literature
- Target-Adverse Events and Fear of Cancer Progression, Anxiety, and Depression in Patients with Advanced Non-Small Cell Lung Cancer
- Volume imaging to interrogate cancer cell-tumor microenvironment interactions in space and time
- Melatonin/Chitosan Biomaterials for Wound Healing and Beyond: A Multifunctional Therapeutic Approach
- Folliculin Deficient Renal Cancer Cells Show Higher Radiosensitivity through Autophagic Cell Death
- ONCO-NK-TRANSITION-GM1: The Bridge Cancer Therapy Manufacturable by Current Pharmaceutical Industry — 60-80% Cure Rate — $50 per Dose A Complete Transitional Drug from Full N‑K GM Series to Current Pharma Capability
- Dynamic changes of gut and skin microbiota in pancreatic cancer-induced skin injury
- Drug Discovery Today: Therapeutic Strategies - 2006 Editorial
- Melatonin-Loaded Nanocarriers: New Horizons for Therapeutic Applications
- Niosomes as Efficient Nanocarriers for Targeted Drug Delivery
- Fibroblast heterogeneity and functions: insights from single-cell sequencing in wound healing, breast cancer, ovarian cancer and melanoma
- Protein degradation: expanding the toolbox to restrain cancer drug resistance
- The role of B cell-activating factor system in autoimmune diseases: mechanisms, disease implications, and therapeutic advances
- Therapeutic Application of Microsponges-based Drug Delivery Systems
- Cannabinoid Compounds as a Pharmacotherapeutic Option for the Treatment of Non-Cancer Skin Diseases